TCMBANKGE001033 |
FGFR1 |
BFGFR; CD331; CEK; ECCL; FGFBR; FGFR-1; FLG; FLT-2; FLT2; HBGFR; HH2; HRTFDS; KAL2; N-SAM; OGD; bFGF-R-1 |
fibroblast growth factor receptor 1 |
TCMBANKGE000235 |
NTRK2 |
EIEE58; GP145-TrkB; OBHD; TRKB; trk-B |
neurotrophic receptor tyrosine kinase 2 |
TCMBANKGE000447 |
TSC2 |
LAM; PPP1R160; TSC4 |
TSC complex subunit 2 |
TCMBANKGE008062 |
DLL3 |
SCDO1 |
delta like canonical Notch ligand 3 |
TCMBANKGE011069 |
DPYSL3 |
CRMP-4; CRMP4; DRP-3; DRP3; LCRMP; ULIP; ULIP-1 |
dihydropyrimidinase like 3 |
TCMBANKGE007197 |
KIAA1549 |
RP86 |
KIAA1549 |
TCMBANKGE000173 |
BRAF |
B-RAF1; B-raf; BRAF1; NS7; RAFB1 |
B-Raf proto-oncogene, serine/threonine kinase |
TCMBANKGE001343 |
UBASH3B |
STS-1; STS1; TULA-2; TULA2; p70 |
ubiquitin associated and SH3 domain containing B |
TCMBANKGE011269 |
ACVR1 |
ACTRI; ACVR1A; ACVRLK2; ALK2; FOP; SKR1; TSRI |
activin A receptor type 1 |
TCMBANKGE000701 |
ESR2 |
ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 |
estrogen receptor 2 |
TCMBANKGE000568 |
MET |
AUTS9; DFNB97; HGFR; RCCP2; c-Met |
MET proto-oncogene, receptor tyrosine kinase |
TCMBANKGE000201 |
ESR1 |
ER; ESR; ESRA; ESTRR; Era; NR3A1 |
estrogen receptor 1 |
TCMBANKGE006825 |
HEY1 |
BHLHb31; CHF2; HERP2; HESR1; HRT-1; NERP2; OAF1; hHRT1 |
hes related family bHLH transcription factor with YRPW motif 1 |
TCMBANKGE004813 |
NKX2-1 |
BCH; BHC; NK-2; NKX2.1; NKX2A; NMTC1; T/EBP; TEBP; TITF1; TTF-1; TTF1 |
NK2 homeobox 1 |
TCMBANKGE007074 |
NDRG1 |
CAP43; CMT4D; DRG-1; DRG1; GC4; HMSNL; NDR1; NMSL; PROXY1; RIT42; RTP; TARG1; TDD5 |
N-myc downstream regulated 1 |
TCMBANKGE000898 |
MYC |
MRTL; MYCC; bHLHe39; c-Myc |
MYC proto-oncogene, bHLH transcription factor |
TCMBANKGE002242 |
HEY2 |
CHF1; GRIDLOCK; GRL; HERP1; HESR2; HRT2; bHLHb32 |
hes related family bHLH transcription factor with YRPW motif 2 |
TCMBANKGE001097 |
HIF1A |
HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8; bHLHe78 |
hypoxia inducible factor 1 subunit alpha |
TCMBANKGE004266 |
AR |
AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM |
androgen receptor |
TCMBANKGE001030 |
NOTCH1 |
AOS5; AOVD1; TAN1; hN1 |
notch receptor 1 |
TCMBANKGE000011 |
DCX |
DBCN; DC; LISX; SCLH; XLIS |
doublecortin |
TCMBANKGE001106 |
MTOR |
FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS |
mechanistic target of rapamycin kinase |
TCMBANKGE010402 |
NF1 |
NFNS; VRNF; WSS |
neurofibromin 1 |
TCMBANKGE007285 |
A1BG |
A1B; ABG; GAB; HYST2477 |
alpha-1-B glycoprotein |
TCMBANKGE011562 |
GLS2 |
GA; GLS; LGA; hLGA |
glutaminase 2 |
TCMBANKGE014567 |
SLC12A3 |
NCC; NCCT; TSC |
solute carrier family 12 member 3 |
TCMBANKGE001059 |
LATS1 |
WARTS; wts |
large tumor suppressor kinase 1 |
TCMBANKGE000328 |
PTPN11 |
BPTP3; CFC; JMML; METCDS; NS1; PTP-1D; PTP2C; SH-PTP2; SH-PTP3; SHP2 |
protein tyrosine phosphatase non-receptor type 11 |
TCMBANKGE007651 |
NOTCH2 |
AGS2; HJCYS; hN2 |
notch receptor 2 |
TCMBANKGE011185 |
TESC |
CHP3; TSC |
tescalcin |
TCMBANKGE000988 |
HGF |
DFNB39; F-TCF; HGFB; HPTA; SF |
hepatocyte growth factor |
TCMBANKGE001056 |
KRAS |
C-K-RAS; C-K-RAS; CFC2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-Ras; K-Ras 2; KI-RAS; KRAS1; KRAS2; NS; NS3; OES; RALD; RASK2; c-Ki-ras; c-Ki-ras2 |
KRAS proto-oncogene, GTPase |
TCMBANKGE000923 |
CDK1 |
CDC2; CDC28A; P34CDC2 |
cyclin dependent kinase 1 |
TCMBANKGE015037 |
TSC1 |
LAM; TSC |
TSC complex subunit 1 |
TCMBANKGE001102 |
MIR21 |
MIRN21; hsa-mir-21; miR-21; miRNA21 |
microRNA 21 |
TCMBANKGE001058 |
LATS2 |
KPM |
large tumor suppressor kinase 2 |
TCMBANKGE011492 |
ANXA6 |
ANX6; CBP68; CPB-II; p68; p70 |
annexin A6 |
TCMBANKGE000696 |
PKD1 |
PBP; PC1; Pc-1; TRPP1 |
polycystin 1, transient receptor potential channel interacting |
TCMBANKGE012196 |
ATRX |
JMS; MRX52; RAD54; RAD54L; XH2; XNP; ZNF-HX |
ATRX chromatin remodeler |
TCMBANKGE000389 |
MMP3 |
CHDS6; MMP-3; SL-1; STMY; STMY1; STR1 |
matrix metallopeptidase 3 |
TCMBANKGE000475 |
NCOA3 |
ACTR; AIB-1; AIB1; CAGH16; CTG26; KAT13B; RAC3; SRC-3; SRC3; TNRC14; TNRC16; TRAM-1; bHLHe42; pCIP |
nuclear receptor coactivator 3 |